Patients exposed to nerve gas agents need to be rapidly triaged and appropriate therapy initiated. Patients are initially separated based on the clinical severity at the time of presentation.
Features of nerve gas exposure:
(1) Absorption may follow inhalation, ingestion or dermal exposure.
(2) The onset of symptoms may be abrupt and follow an asymptomatic interval of up to 18 hours.
Clinical Severity |
Appearance |
Signs and Symptoms |
---|---|---|
light |
person able to walk |
lacrimation, tearing salivation nasal discharge miosis blurred vision stenocardia (angina pectoris) sweating nausea and vomiting abdominal pain |
moderate |
person unable to walk but breathing spontaneously |
findings above, plus dyspnea wheezing feeling of weakness tremor, muscle fasciculations diarrhea urinary frequency
generalized muscle fasciculations (*) incontinence of stool and/or urine (*) loss of consciousness, coma (*) |
severe |
person not breathing |
findings above, plus respiratory failure, apnea epileptic seizures flaccid paralysis |
(*) These symptoms seem to be moderate-to-severe. They are listed as signs of severe exposure in Table 59-6, page 1271, Ellenhorn (1997).
Purpose: To grade the severity of symptoms following exposure to a nerve gas so that appropriate therapy can be given.
Specialty: Toxicology, Emergency Medicine, Critical Care
Objective: severity, prognosis, stage
ICD-10: T59,